Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGWP.L Regulatory News (GWP)

  • There is currently no data for GWP

Director/PDMR Shareholding

18 Jul 2008 16:38

RNS Number : 4435Z
GW Pharmaceuticals PLC
18 July 2008
 
 
 
18 July 2008
 
GW Pharmaceuticals plc
("GW" or "the Company")
 
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
 
The company was notified on 17th July 2008 that two connected persons of Dr Geoffrey Guy, a Director of the Company, each gifted 52,000 ordinary shares of 0.1p for nil consideration to a family member. The total number of shares gifted of 104,000 represents 0.09% of the issued share capital.
 
Following this notification Dr Guy and his connected parties have a beneficial Interest in 21,290,663 ordinary shares, amounting to 17.6% of the shares in issue.
 
Enquiries:
GW Pharmaceuticals plc
01980 557000
Adam George, Company Secretary
 
 
 
This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSILFFEDIITLIT
Date   Source Headline
20th Apr 20057:00 amRNSDirector Shareholding
19th Apr 200511:38 amRNSProduct Approval
5th Apr 200510:31 amRNSBlocklisting Interim Review
24th Mar 20059:26 amRNSAdditional Listing
23rd Mar 20057:00 amRNSAppointment
23rd Mar 20057:00 amRNSAGM Resolutions
2nd Mar 20052:05 pmRNSDirector Shareholding
2nd Mar 200510:36 amRNSAdditional Listing
28th Feb 20052:05 pmRNSRe: US Strategy
19th Jan 20057:00 amRNSResearch Update
19th Jan 20057:00 amRNSFinal Results
10th Jan 20052:01 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.